Is monitoring of FOXP3 Treg cells in renal transplants during acute cellular rejection episodes useful?

Clinical Nephrology

Volumn 75, Issue 2, 2011, Pages 101-106

  Batsford, S ^a   Dickenmann, M ^b   Durmuller U ^a   Hopfer, H ^a   Gudat, F ^a   Mihatsch, M ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

FOXP3; Kidney graft rejection; Renal transplantation; Treg cells

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT REJECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MONITORING; RETROSPECTIVE STUDY; T LYMPHOCYTE SUBPOPULATION;

ACUTE DISEASE; BIOLOGICAL MARKERS; BIOPSY; FLUORESCENT ANTIBODY TECHNIQUE; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; RETROSPECTIVE STUDIES; SWITZERLAND; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; UP-REGULATION;

EID: 79251491371     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.2379/CNP75101     Document Type: Article

References (18)

1. Jiang H, Chess L. Regulation of immune responses by T cells. N Engl J Med. 2006; 354: 1166-1176.
2. Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol. 2008; 9: 239-244.
3. Veronese F, Rotman S, Smith RN, Pelle TD, Farrell ML, Kawai T, Benedict Cosimi A, Colvin RB. Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection. Am J Transplant. 2007; 7: 914-922.
4. Chaput NS, Louafi A, Bardier F, Charlotte JC, Vaillant F, Menegaux M, Rosenzwajg F, Lemoine D, Klatzmann, Taieb J. Identification of CD8+ CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Gut. 2009; 58: 520-529.
5. Bestard O, Cruzado JM, Mestre M, Caldes A, Bas A, Carrera M, Torras J, Rama I, Moreso F, Seron D, Grinyo JM. Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. J Immunol. 2007; 179: 4901-4909.
6. Bestard O, Cruzado JM, Rama I, Torras J, Goma M, Seron D, Moreso F, Gil-Vernet S, Grinyo JM. Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol. 2008; 19: 2020-2026.
7. Codarri L, Vallotton L, Ciuffreda D, Venetz JP, Garcia M, Hadaya K, Buhler L, Rotman S, Pascual M, PantaleoG. Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7R-alphahigh cell population in solid organ transplant recipients. J Exp Med. 2007; 204: 1533-1541.
8. Mansour H, Homs S, Desvaux D, Badoual C, Dahan K, Matignon M, Audard V, Lang P, Grimbert P. Intragraft levels of foxp3 mRNA predict progression in renal transplants with borderline change. J Am Soc Nephrol. 2008; 19: 2277-2281.
9. Muthukumar T, Dadhania D, Ding R, Snopkowski C, Naqvi R, Lee JB, Hartono C, Li B, Sharma VK, Seshan SV, Kapur S, Hancock WW, Schwartz JE, Suthanthiran M. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med. 2005; 353: 2342-2351.
10. Grimbert P, Mansour H, Desvaux D, Roudot-Thoraval F, Audard V, Dahan K, Berrehar F, Dehoulle-Poillet C, Farcet JP, Lang P, Le Gouvello S. The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection. Transplantation. 2007; 83: 341-346.
11. Eisenberger U, Seifried A, Patey N, Kappeler A, Noel LH, Frey FJ, Korner M. FoxP3 positive T cells in graft biopsies from living donor kidney transplants after donor-specific transfusions. Transplantation. 2009; 87: 138-142.
12. Bunnag S, Allanach K, Jhangri GS, Sis B, Einecke G, Mengel M, Mueller TF, Halloran PF. FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes.AmJ Transplant. 2008; 8: 1423-1433.
13. Yapici U, Bemelman FJ, Scheepstra CG, Roelofs JJ, Claessen N, van der Loos C, van Donselaarvan der Pant K, Bouts AH, Idu MM, Rowshani AT, ten Berge IJ, Florquin S. Intragraft FOXP3 protein or mRNA during acute renal allograft rejection correlates with inflammation, fibrosis, and poor renal outcome. Transplantation. 2009; 87: 1377-1380.
14. Ashton-Chess J, Dugast E, Colvin RB, Giral M, Foucher Y,Moreau A, Renaudin K, Braud C, Devys A, Brouard S, Soulillou JP. Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients. J Am Soc Nephrol. 2009; 20: 1113-1122.
15. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, EineckeG, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008; 8: 753-760. (Pubitemid 351347767)
16. Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ. Histological characteristics of interstitial renal allograft rejection. Kidney Blood Press Res. 1998; 21: 230-232.
17. Chauhan SK, Saban DR, Lee HK, Dana R. Levels of Foxp3 in regulatory t cells reflect their functional status in transplantation. J Immunol. 2009; 182: 148-153.
18. Feuerer M, Hill JA, Mathis D, Benoist C. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol.2009; 10: 689-695.